Optimal dosing of high-dose melphalan prior to autologous hematopoietic stem cell transplantation in a patient with AL amyloidosis and a solitary kidney

Shin Yin Lee; Dina Brauneis; Lauren Stern; Vaishali Sanchorawala

首页> 外文期刊>Hematology/Oncology and Stem Cell Therapy >Optimal dosing of high-dose melphalan prior to autologous hematopoietic stem cell transplantation in a patient with AL amyloidosis and a solitary kidney

【24h】

Optimal dosing of high-dose melphalan prior to autologous hematopoietic stem cell transplantation in a patient with AL amyloidosis and a solitary kidney

机译：AL淀粉样变性病和孤立肾患者自体造血干细胞移植前高剂量美法仑的最佳剂量

获取原文

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Hematology/Oncology and Stem Cell Therapy》 |2016年第2期|共3页
作者
Shin Yin Lee; Dina Brauneis; Lauren Stern; Vaishali Sanchorawala;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类一般性问题;
关键词

相似文献

外文文献
中文文献
专利

1. High-Dose Melphalan and Autologous Hematopoietic Stem Cell Transplantation in Primary Amyloidosis: Single-Center Results [J] . Charlinski G., Ziarkiewicz M., Boguradzki P., Transplantation Proceedings . 2014,第8期

机译：原发性淀粉样变性中的大剂量美法仑和自体造血干细胞移植：单中心结果
2. The Effect of Bone Marrow Plasma Cell Burden on Survival in Patients with Light Chain Amyloidosis Undergoing High-Dose Melphalan and Autologous Stem Cell Transplantation [J] . Dittus Christopher, Uwumugambi Nsabimana, Sun Fangui, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2016,第9期

机译：大剂量美法兰和自体干细胞移植对轻链淀粉样变性病患者骨髓浆细胞负荷的影响
3. Spontaneous rupture of the liver in a patient with systemic AL amyloidosis undergoing treatment with high-dose melphalan and autologous stem cell transplantation: a case report with literature review. [J] . Tam M, Seldin DC, Forbes BM, Amyloid: the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis . 2009,第2期

机译：接受大剂量美法仑和自体干细胞移植治疗的系统性AL淀粉样变性患者的肝脏自发性破裂：一例报道并文献复习。
4. HIGH-DOSE MELPHALAN CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN 65 PATIENTS WITH AL AMYLOIDOSIS: ORGAN PROGRESSION CAN BE DELAYED IN PATIENTS REACHING COMPLETE REMISSION [C] . SO Schonland, J.B Dengler, M Hundemer, International Symposium on Amyloidosis . 2008

机译：在65例Al淀粉样蛋白患者中，具有自体蛋白化疗的高剂量蛋白化疗：器官进展可以延迟达到完全缓解的患者
5. Posttraumatic stress disorder and sub-syndromal trauma symptoms in cancer patients treated with autologous hematopoietic stem cell transplant and standard dose chemotherapy. [D] . Gourvitz, Ross L. 2008

机译：自体造血干细胞移植和标准剂量化疗治疗的癌症患者的创伤后应激障碍和综合征下创伤症状。
6. Pre-transplantation novel agent induction predicts progression-free survival for patients with immunoglobulin light-chain amyloidosis undergoing high-dose melphalan and autologous stem-cell transplantation [O] . Andrew J. Cowan, Zandra K. Klippel, Philip A. Stevenson, -1

机译：移植前新型药物诱导可预测接受大剂量美法仑和自体干细胞移植的免疫球蛋白轻链淀粉样变性患者的无进展生存期
7. Optimal dosing of high-dose melphalan prior to autologous hematopoietic stem cell transplantation in a patient with AL amyloidosis and a solitary kidney [O] . Lee Shin Yin, Brauneis Dina, Stern Lauren, 2016

机译：AL淀粉样变性和单肾的患者自体造血干细胞移植前大剂量美法仑的最佳剂量
8. Development and Application of Cellular Sensitivity Biomarkers for the Detectionand Measurement of Toxic Effects in Normal and Malignant Cells from Patients Receiving High-Dose Melphalan with Autologous Peripheral Blood Progenitor Cell Rescue in the Treat [R] . Peters, W. P., Hussein, A. M., Vredenburgh, J. J. 1997

机译：细胞敏感性生物标志物的开发和应用，用于检测和测量接受大剂量美法仑治疗的患者正常和恶性细胞的毒性作用，自体外周血祖细胞拯救治疗

Optimal dosing of high-dose melphalan prior to autologous hematopoietic stem cell transplantation in a patient with AL amyloidosis and a solitary kidney

著录项

引文网络

相似文献

相关主题

期刊订阅